| 4.92 0.13 (2.71%) | 01-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.9 |
1-year : | 8.39 |
| Resists | First : | 5.91 |
Second : | 7.19 |
| Pivot price | 5.54 |
|||
| Supports | First : | 3.83 | Second : | 3.19 |
| MAs | MA(5) : | 5.55 |
MA(20) : | 5.62 |
| MA(100) : | 5.62 |
MA(250) : | 5.42 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 49.4 |
D(3) : | 56.5 |
| RSI | RSI(14): 37.5 |
|||
| 52-week | High : | 9.19 | Low : | 2.92 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AIRS ] has closed above bottom band by 8.9%. Bollinger Bands are 20.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.99 - 5.02 | 5.02 - 5.05 |
| Low: | 4.42 - 4.46 | 4.46 - 4.49 |
| Close: | 4.87 - 4.92 | 4.92 - 4.97 |
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Mon, 13 Jan 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Mon, 13 Jan 2025
Tech Stocks Plunge: Comtech, AirSculpt, D-Wave and More See Major Losses Amid Market Volatility - HPBL
Mon, 13 Jan 2025
AirSculpt Technologies, Inc. Updates Earnings Guidance for the Fiscal Year 2024 - Marketscreener.com
Mon, 13 Jan 2025
AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025 - The Manila Times
Mon, 13 Jan 2025
AirSculpt Lowers 2024 Guidance as New CEO Plans Operational Overhaul - StockTitan
Tue, 07 Jan 2025
AirSculpt Technologies Announces Participation in the ICR Conference 2025 - Quantisnow
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 58 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 26.6 (%) |
| Held by Institutions | 73.2 (%) |
| Shares Short | 2,280 (K) |
| Shares Short P.Month | 1,820 (K) |
| EPS | -0.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.42 |
| Profit Margin | -4.2 % |
| Operating Margin | -8.8 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | -9.4 % |
| Qtrly Rev. Growth | -9.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 3.26 |
| EBITDA (p.s.) | 0.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 14 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -35.15 |
| PEG Ratio | 0 |
| Price to Book value | 3.44 |
| Price to Sales | 1.5 |
| Price to Cash Flow | 21.09 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 8.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|